Sheldon L. Miller

585 total citations
16 papers, 435 citations indexed

About

Sheldon L. Miller is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Sheldon L. Miller has authored 16 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Clinical Biochemistry and 4 papers in Physiology. Recurrent topics in Sheldon L. Miller's work include Metabolism and Genetic Disorders (4 papers), Biochemical effects in animals (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Sheldon L. Miller is often cited by papers focused on Metabolism and Genetic Disorders (4 papers), Biochemical effects in animals (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Sheldon L. Miller collaborates with scholars based in United States, Switzerland and Chile. Sheldon L. Miller's co-authors include Pierre Morell, Joyce A. Benjamins, Richard C. Wiggins, Martin R. Krigman, David Pleasure, F. Arthur McMorris, Oded Abramsky, Marc Yudkoff, Yevgeny Daikhin and Andreas Steck and has published in prestigious journals such as Journal of Biological Chemistry, Brain and Neurology.

In The Last Decade

Sheldon L. Miller

16 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheldon L. Miller United States	11	196	109	108	78	71	16	435
J. A. Burdman Argentina	19	321 1.6×	96 0.9×	109 1.0×	25 0.3×	79 1.1×	51	794
Judith A. Kelleher United States	10	169 0.9×	82 0.8×	100 0.9×	43 0.6×	20 0.3×	12	348
M. L. Harpin France	10	219 1.1×	125 1.1×	53 0.5×	53 0.7×	27 0.4×	15	371
Rita Mozzi Italy	14	301 1.5×	97 0.9×	80 0.7×	58 0.7×	34 0.5×	37	550
Douglas G. McCartney Canada	13	265 1.4×	128 1.2×	84 0.8×	32 0.4×	20 0.3×	25	405
Maria Luisa Eboli Italy	12	328 1.7×	88 0.8×	62 0.6×	38 0.5×	19 0.3×	22	463
P. Homayoun France	11	237 1.2×	85 0.8×	58 0.5×	17 0.2×	56 0.8×	17	431
Yibing Li China	9	310 1.6×	108 1.0×	142 1.3×	22 0.3×	62 0.9×	15	665
Carmen Arizmendi Spain	9	255 1.3×	136 1.2×	58 0.5×	97 1.2×	12 0.2×	11	494
Ioanna Sevastou United Kingdom	11	361 1.8×	107 1.0×	68 0.6×	22 0.3×	40 0.6×	13	607

Countries citing papers authored by Sheldon L. Miller

Since Specialization

Citations

This map shows the geographic impact of Sheldon L. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon L. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon L. Miller more than expected).

Fields of papers citing papers by Sheldon L. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheldon L. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon L. Miller. The network helps show where Sheldon L. Miller may publish in the future.

Co-authorship network of co-authors of Sheldon L. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Sheldon L. Miller. A scholar is included among the top collaborators of Sheldon L. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheldon L. Miller. Sheldon L. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Górny, Miroslaw K., Zofia Wróblewska, David Pleasure, et al.. (2009). CSF antibodies to myelin basic protein and oligodendrocytes in multiple sclerosis and other neurological diseases. Acta Neurologica Scandinavica. 67(6). 338–347. 6 indexed citations

Miller, Sheldon L., et al.. (1998). Cycloserine‐induced decrease of cerebroside in myelin. Lipids. 33(4). 441–443. 11 indexed citations

Miller, Sheldon L., Yevgeny Daikhin, & Marc Yudkoff. (1996). Metabolism of N-acetyl-l-aspartate in rat brain. Neurochemical Research. 21(5). 615–618. 21 indexed citations

Gabriel, J M, Beat Erne, G Miescher, et al.. (1996). Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy. Brain. 119(3). 775–787. 43 indexed citations

Miller, Sheldon L., et al.. (1989). Detection and partial biochemical characterization of a novel 57,500 Dalton protein in rat brain myelin. Journal of Neuroscience Research. 22(3). 262–268. 3 indexed citations

Sergott, Robert C., Mark J. Brown, Robert P. Lisak, & Sheldon L. Miller. (1988). Antibody to myelin‐associated glycoprotein produces central nervous system demyelination. Neurology. 38(3). 422–422. 21 indexed citations

Miller, Sheldon L., Sidney N. Kahn, B Perussia, & Giorgio Trinchieri. (1987). Comparative binding of murine and human monoclonal antibodies reacting with myelin-associated glycoprotein to myelin and human lymphocytes. Journal of Neuroimmunology. 15(3). 229–242. 7 indexed citations

Miller, Sheldon L., David Pleasure, Meenhard Herlyn, et al.. (1984). Production and Characterization of Monoclonal Antibodies to Peripheral and Central Nervous System Myelin. Journal of Neurochemistry. 43(2). 394–400. 21 indexed citations

Miller, Sheldon L., et al.. (1984). Effect of essential fatty acid deficiency on myelin proteins. Lipids. 19(6). 478–480. 6 indexed citations

10.

Miller, Sheldon L., et al.. (1981). Effect of essential fatty acid deficiency on the synthesis and turnover of myelin lipid. Journal of Neuroscience Research. 6(2). 203–210. 4 indexed citations

11.

McMorris, F. Arthur, Sheldon L. Miller, David Pleasure, & Oded Abramsky. (1981). Expression of biochemical properties of oligodendrocytes in oligodendrocyte x glioma cell hybrids proliferating in vitro. Experimental Cell Research. 133(2). 395–404. 30 indexed citations

12.

Miller, Sheldon L. & Pierre Morell. (1978). TURNOVER OF PHOSPHATIDYLCHOLINE IN MICROSOMES AND MYELIN IN BRAINS OF YOUNG AND ADULT RATS. Journal of Neurochemistry. 31(4). 771–777. 12 indexed citations

13.

Miller, Sheldon L., Joyce A. Benjamins, & Pierre Morell. (1977). Metabolism of glycerophospholipids of myelin and microsomes in rat brain. Reutilization of precursors.. Journal of Biological Chemistry. 252(12). 4025–4037. 69 indexed citations

14.

Wiggins, Richard C., Sheldon L. Miller, Joyce A. Benjamins, Martin R. Krigman, & Pierre Morell. (1976). Myelin synthesis during postnatal nutritional deprivation and subsequent rehabilitation. Brain Research. 107(2). 257–273. 93 indexed citations

15.

Benjamins, Joyce A., Sheldon L. Miller, & Pierre Morell. (1976). METABOLIC RELATIONSHIPS BETWEEN MYELIN SUBFRACTIONS: ENTRY OF GALACTOLIPIDS AND PHOSPHOLIPIDS ¹. Journal of Neurochemistry. 27(2). 565–570. 74 indexed citations

16.

Miller, Sheldon L., et al.. (1975). Reutilization of choline for synthesis of phosphatidyl choline and choline plasmalogen in rat brain. Journal of Neurochemistry. 25(6). 913–914. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact